Edwards Lifesciences Total Debt

EW -- USA Stock  

USD 139.77  0.38  0.27%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Total Debt Analysis

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
Edwards Lifesciences 
Total Debt 
1.19 B

Total Debt Over Time Pattern

 Edwards Lifesciences Total Debt 

About Total Debt

In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Edwards Lifesciences Total Debt Assessment


Edwards Lifesciences Debt Changes

Debt Current

Debt Non Current

Based on latest financial disclosure Edwards Lifesciences Corporation has Total Debt of 1.19 B. This is 50.4% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Total Debt for all stocks is 83.83% higher than the company.

Peer Comparison

Edwards Lifesciences Total Debt Comparison
  Total Debt 
      Edwards Lifesciences Comparables 
Edwards Lifesciences is rated below average in total debt category among related companies.